Glaritus 40IU/ml Injection
By Glaritus
Rx
10ml Injection in a Vial

Composition
Insulin Glargine(40IU)

Manufacturer - Wockhardt Ltd
Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400051, Maharashtra, India

Expires on or after
July, 2025

liver
When it comes to the safety of using Glaritus 40IU/ml Injection in patients with liver disease, caution is advised. It is important to be careful when administering this injection to individuals with liver issues. Dosage adjustments may be necessary, so it is vital to consult with your doctor before using Glaritus 40IU/ml Injection. Regular monitoring of glucose levels is also recommended to ensure proper dose adjustment and overall safety in patients with liver concerns.

kidney
Glaritus 40IU/ml Injection should be used carefully in patients with kidney disease. Dose adjustment may be necessary, so consult your doctor. Regular blood glucose monitoring is advised for dose adjustment.

alcohol
It is not safe to drink alcohol while using Glaritus 40IU/ml Injection.

driving
When using Glaritus 40IU/ml Injection, avoid driving if experiencing low or high blood sugar symptoms that impair focus and reaction time. Your ability to drive may be affected in such conditions.

pregnancy
During pregnancy, Glaritus 40IU/ml Injection is commonly deemed safe based on animal studies with minimal adverse effects observed. Limited human studies are available, hence caution is advised.

breastfeeding
During breastfeeding, Glaritus 40IU/ml Injection is considered safe based on limited human data, indicating minimal risk to the baby.
Habit Forming | No |
Chemical Class | Insulin analogue |
Therapeutic Class | - |
Action Class | Insulin analogues- long acting |
₹1142.86
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025